A California company has created a first-of-its-kind eyedrop that corrects a certain type of vision impairment and could ...

LENZ Therapeutics recently received FDA approval for its Vizz eye drops to treat presbyopia in adults, offering a new non-surgical solution for age-related farsightedness. This regulatory milestone ...

"This FDA approval represents a disruptive paradigm shift in treatment options for millions of people who are frustrated and ...

The Food and Drug Administration has approved the first aceclidine-based eye drop designed to improve near vision in adults ...

Presbyopia is a common variant of farsightedness affecting over 128 million people in the US, including the majority of ...

Reading glasses might be the next thing to go the way of the flip phone. The FDA just approved VIZZ, a once-daily eye drop that helps you see up close without glasses. That’s a big deal if you’re over ...

Known as Vizz, the once-daily eye drops treat age-related blurry near vision — also known as presbyopia — for up to 10 hours ...

Lenz Therapeutics has received approval from the Food and Drug Administration for Vizz (aceclidine ophthalmic solution) 1.44% ...

It is anticipated that Vizz, manufactured by Lenz Therapeutics, will become commercially available in the US by the end of ...

Conference call and webcast to be held August 1, 2025 at 8:00 a.m. EDT ...

Detailed price information for Lenz Therapeutics Inc (LENZ-Q) from The Globe and Mail including charting and trades.